Forbes Article Poses Questions Is the FDA Approving Drugs Too Quickly?

There is an interesting article, Is the FDA Approving Drugs Too Quickly? (9/12/12) in Forbes written by John LaMattina, Former president of Pfizer R&D/senior partner at PureTech Venture.  To read the article click here